Dainippon Sumitomo Pharma Kicks Off Orphan Aid Program
This article was originally published in PharmAsia News
China's Children and Teenagers' Fund and Dainippon Sumitomo Pharma Suzhou recently started a project for helping school-age orphans. The program aims to publicize the living and educational conditions of ethnic orphans in remote and poverty-stricken areas to encourage more people to participate in the care of such children. As a major proponent of the activity, Dainippon Sumitomo donated special funds to a school in Yunnan to help 50 orphans complete junior high school. (Click here for more - Chinese Language)
You may also be interested in...
Companies are racing to co-develop coronavirus treatments before finalizing deal teams. These team-ups raise questions about what happens after the pandemic subsides.
Plaintiffs against the prestige, “clinical” skin-care company are targeting anti-aging claims on its Rose Stem Cell Bio-Repair line and statements about hyaluronic acid’s ultra-moisturizing capabilities, used to market its Water Drench range. PTR faces false advertising class actions in California and New York federal courts, and the former case appears to be headed for trial.
Flagship Pioneering raised $1.1bn to fund life science companies emerging from Flagship Labs. ARCH, another frequent start-up co-founder, raised two funds totaling $1.46bn to back early-stage biotech.